Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      7 trials found for Urothelial, Bladder cancer

      All(7)
      Recruiting(7)
      Not yet recruiting(0)
      2 trials recruiting
      1 trial not yet recruiting
      Be6A Clinical Trials

      Evaluating sigvotatug vedotin to see if it will extend life expectancy and increase the period before cancer recurs.

      Recruiting
      NCT05911295
      Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

      Urothelial Carcinoma

      Male or Female
      18+ years
      101study location(s)
      Recruiting
      NCT04879329
      A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

      Urothelial Carcinoma

      Male or Female
      18+ years
      79study location(s)
      Recruiting
      NCT05902494
      HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

      Urothelial Carcinoma

      Male or Female
      18+ years
      19study location(s)
      Recruiting
      NCT05775471
      Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer

      Renal Pelvis and Ureter Urothelial Carcinoma

      Male or Female
      18+ years
      1study location(s)
      Recruiting
      NCT04389632
      A Study of SGN-B6A in Advanced Solid Tumors

      Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

      Male or Female
      18+ years
      44study location(s)
      Recruiting
      NCT06580938
      A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer

      Non Small Cell Lung Cancer, Bladder Cancer, Renal Cell Carcinoma, Melanoma, Head and Neck Cancer, Colorectal Cancer

      Male or Female
      18+ years
      16study location(s)
      Recruiting
      NCT05366725
      OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH ADVANCED UROTHELIAL CANCER AFTER CHEMOTHERAPY

      Urothelial Cancer

      Male or Female
      18+ years
      1study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(7)
      Recruiting(7)
      Not yet recruiting(0)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.